Skip to main content


Health

"There is concern that with a license for multiple sclerosis, the cost of alemtuzumab could rise and might become too expensive for many patients and health systems," an editorial in the medical journal the Lancet warns.
621 of 1604



Newsletter Sign Up

Daily Readings

Reading 1, Revelation 20:1-4, 11--21:2
Then I saw an angel come down from heaven with the key of the ... Read More

Psalm, Psalms 84:3, 4, 5-6, 8
Even the sparrow has found a home, the swallow a nest to place ... Read More

Gospel, Luke 21:29-33
And he told them a parable, 'Look at the fig tree and indeed ... Read More

Saint of the Day

November 28 Saint of the Day

St. Catherine Laboure
November 28: St. Catherine Laboure, virgin, was born on May 2, 1806. At an ... Read More